BMO Capital Markets adjusted its stance on Q32 Bio Inc. (NASDAQ: QTTB), downgrading the biotechnology firm's stock rating from Outperform to Market Perform, accompanied by a significant decrease in ...

Alimentation Couche-Tard (TSE:ATD – Get Free Report) had its target price dropped by investment analysts at BMO Capital Markets from C$87.00 to C$85.00 in a research report issued on Monday,BayStreet.

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

IGM Financial (TSE:IGM – Get Free Report) had its price target raised by investment analysts at BMO Capital Markets from C$47.00 to C$48.00 in a research report issued on Monday,BayStreet.CA reports.

Wednesday's consumer-price index for January looms in the minds of bond-market participants, as investors and traders also remain focused on the prospect of trade wars between the U.S. and other ...

BMO Capital downgraded Q32 Bio (QTTB) to Market Perform from Outperform with a price target of $3, down from $22. The company announced an ...

U.S. government debt was little changed overnight and into Monday morning, despite President Donald Trump's intention to impose 25% tariffs on all steel and alum ...

Find insight on Coty, homebuying sentiment, Uber Technologies, and more in the latest Market Talks covering Financial ...

BMO Capital Markets downgraded Everest Group to Market Perform due to deeper underwriting issues and a $1.7B reserve charge, ...